Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AxoGen Inc.

www.axogeninc.com

Latest From AxoGen Inc.

First US FDA RMAT Designation Of 2019 Goes To ExCellThera’s ECT-001

Five-month drought broken by ExCellThera’s "optimized culture system" designation for treatment of hematologic malignancies. The Pink Sheet details each of the 27 announced Regenerative Medicine Advanced Therapy designations in a table.
Cancer Review Pathway

Axogen Expands RECON Study Of Avance Nerve Graft

The study will be expanded by 50 patients, for a total of 220 subjects, based on the recommendation of a statistician who reviewed an interim analysis. RECON is intended to support a Biologic License Application for Avance, a processed human nerve allograft for bridging severed peripheral nerves.

Clinical Trials Starts & Stops

Starts & Stops: Boston Scientific Launches New Lotus TAVR Trial, Medtronic Starts Study Of SynchroMed II Pain Pump

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by MedDeviceTracker. This edition covers trial announcements from Jan. 7 through Jan. 27, including announcements from Medtronic, QT Vascular, Boston Scientific, and Shockwave.

Starts & Stops Tracking Trials

Deals Shaping The Medical Industry, December 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AxoGen Inc.
  • Senior Management
  • Karen Zaderej, Chmn., Pres. & CEO
    Peter J Mariani, CFO
    Gregory G Freitag, General Counsel, SVP & Dir., Bus. Dev.
    Jon Gingrich, Chief Commercial Officer
    Shawn McCarrey, SVP, Sales
    Kevin Leach, VP, Mktg.
    Mike Donovan, VP, Operations
  • Contact Info
  • AxoGen Inc.
    Phone: (386) 462-6800
    13859 Progress Blvd.
    Ste. 400
    Alachua, FL 32615
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register